Health Insurers Commit to Reform Prior Authorization Process Amid Criticism
By Berkeley Lovelace Jr. | Smart Money Mindset
Date: June 23, 2025
In a significant announcement, Health and Human Services Secretary Robert F. Kennedy Jr. revealed that several of the nation’s largest health insurance providers have pledged to reform the controversial prior authorization process, a mechanism criticized for delaying essential healthcare services for patients. This commitment aims to address growing concerns over the accessibility of care for insured individuals.
Understanding Prior Authorization
Prior authorization is a cost-control strategy endorsed by insurers, necessitating their approval before patients can undergo specific medical tests, treatments, or acquire prescribed medications. This requirement frequently leads to lengthy waits, potentially jeopardizing patient health, as it can delay or even deny necessary services.
Recent incidents have heightened scrutiny of the prior authorization system, notably the tragic shooting of Brian Thompson, CEO of UnitedHealth’s insurance subsidiary, in New York. This event has brought renewed urgency to discussions about prior authorization, which many patients and healthcare providers argue creates excessive barriers to timely care.
According to a survey conducted by KFF, a health policy research organization, approximately one in six insured adults have experienced challenges related to prior authorization, highlighting the prevalence of this issue.
Pledges from Major Insurers
Kennedy’s announcement included commitments from several prominent insurance companies, such as the Blue Cross Blue Shield Association, Cigna, Elevance Health, GuideWell, Humana, Kaiser Permanente, and UnitedHealthcare. These changes will span across private insurance, Medicare Advantage, and Medicaid, with the trade group AHIP estimating that approximately 257 million Americans could benefit from these reforms.
Key changes outlined by the insurers include:
-
Continuity of Care: Beginning next year, patients switching insurance plans while undergoing treatment will have their prior authorizations honored for similar services for up to 90 days.
-
Clarity in Communication: Insurers are expected to provide clearer and more comprehensible explanations for denied authorizations, alongside guidance on how to file appeals.
-
Streamlined Processes: Insurers plan to enhance the efficiency of online submission processes for prior authorizations, aiming for at least 80% of electronic requests to receive real-time responses by the year 2027. 4. Reduction in Service Scope: Plans may eliminate prior authorizations for certain medical services in specific regions, although detailed commitments regarding this stipulation remain unspecified.
Expert Opinions and Skepticism
While these commitments are seen as steps in the right direction, health experts emphasize that prior authorization will not disappear entirely. Dr. Adam Gaffney, a critical care physician and assistant professor at Harvard Medical School, noted that while the promised reforms could streamline some processes, they are likely to be limited and incremental. He pointed out that similar pledges have been made in the past without effective implementation, indicating a pattern of unmet promises.
Kaye Pestaina, director of patient and consumer protection at KFF, acknowledged that some of the pledged reforms, like honoring existing prior authorizations during plan transitions, could have tangible benefits for patients. However, the effectiveness of these changes will rely heavily on their actual execution by insurers.
Looking Ahead
Kennedy and Dr. Mehmet Oz, the administrator of the Centers for Medicare & Medicaid Services (CMS), recognized the skepticism surrounding the promises made by insurers, emphasizing the need for systematic change in the healthcare landscape. The recent commitments reflect an urgent response to public outcry over the injustices faced in accessing care.
As the situation develops, both patients and healthcare providers will be closely monitoring how effectively these reforms are implemented and whether they will genuinely alleviate the bureaucratic hurdles associated with prior authorization in the healthcare system.
About the Author
Berkeley Lovelace Jr. is a health and medical reporter at NBC News, focusing on the Food and Drug Administration, with an emphasis on CDC updates, healthcare policy, and advancements in pharmaceuticals. He has a dedicated background in reporting on the biotech industry and medical research.